rs199473625
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP2PP3PP5
The NM_000335.5(SCN5A):āc.4975A>Gā(p.Ile1659Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000675 in 1,613,942 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000335.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.4978A>G | p.Ile1660Val | missense_variant | Exon 28 of 28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.4975A>G | p.Ile1659Val | missense_variant | Exon 28 of 28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.4978A>G | p.Ile1660Val | missense_variant | Exon 28 of 28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.4975A>G | p.Ile1659Val | missense_variant | Exon 28 of 28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152050Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251490Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135920
GnomAD4 exome AF: 0.0000670 AC: 98AN: 1461892Hom.: 1 Cov.: 35 AF XY: 0.0000646 AC XY: 47AN XY: 727246
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152050Hom.: 0 Cov.: 31 AF XY: 0.0000539 AC XY: 4AN XY: 74258
ClinVar
Submissions by phenotype
not provided Pathogenic:7Uncertain:2
- -
- -
- -
- -
Reported in association with LQTS, Brugada syndrome, and cardiomyopathy, though several individuals harbored additional variants (Napolitano et al., 2005; Cordeiro et al., 2006; Kapplinger et al., 2010; Postema et al., 2011; van Waning et al., 2018; van Lint et al., 2019; Burstein et al., 2021); Identified in an individual with Brugada syndrome who also harbored another SCN5A missense variant in trans; however, neither variant presented with Brugada syndrome when inherited alone (Cordeiro et al., 2006); Reported in one individual with a severe phenotype of mixed LQTS/Brugada features who also harbored an SCN5A gain-of-function variant (Postema et al., 2011); Observed in multiple unrelated individuals referred for cardiac genetic testing at GeneDx; however, segregation data for these families are inconclusive and one individual harbored an additional variant in another arrhythmia-related gene; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26187847, 24136861, 20129283, 22581653, 19336922, 18616619, 18436145, 30203441, 33131149, 20812931, 16414944, 17075016, 29402340, 29759671, 29728395, 32268277, 29709101, 29447731, 32048431, 30291343, 30847666, 29709244, 32746448, 31677787, 32569262, 34697415, 34649698) -
- -
- -
- -
This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1660 of the SCN5A protein (p.Ile1660Val). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with Brugada syndrome, dilated cardiomyopathy, and/or long QT syndrome (PMID: 16414944, 20812931, 26173111, 29709101, 29759671, 30847666; internal data). ClinVar contains an entry for this variant (Variation ID: 67947). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SCN5A function (PMID: 17075016). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Dilated cardiomyopathy 1E Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.I1660V variant (also known as c.4978A>G), located in coding exon 27 of the SCN5A gene, results from an A to G substitution at nucleotide position 4978. The isoleucine at codon 1660 is replaced by valine, an amino acid with highly similar properties. This alteration has been detected in long QT syndrome (LQTS), Brugada syndrome, and left ventricular non-compaction (LVNC) cohorts and a subject with hypertrophic cardiomyopathy (HCM); however, clinical details were limited, and some cases had additional cardiac variants detected (Napolitano C et al. JAMA. 2005;294:2975-80; Kapplinger JD et al. Heart Rhythm. 2010;7:33-46; Selga E et al. PLoS ONE, 2015 Jul;10:e0132888; van Waning JI et al. J. Am. Coll. Cardiol., 2018 02;71:711-722; Amin AS et al. Int J Cardiol, 2018 Sep;266:128-132; Burstein DS et al. Pediatr Res, 2021 05;89:1470-1476). This alteration was described in an individual reported to have Brugada syndrome, who carried another SCN5A variant on the second allele. The proband's father and daughter who had this alteration in isolation did not display ECG phenotypes diagnostic of Brugada syndrome (Cordeiro JM et al. Circulation. 2006;114:2026-33). This alteration has also been reported in a healthy Dutch cohort and as a secondary finding in a whole exome sequencing cohort (Haer-Wigman L et al. Eur J Hum Genet, 2019 02;27:325-330; Diebold I et al. Hum Mutat, 2020 05;41:1025-1032). This alteration was also reported in an individual who also carried a gain-of-function mutation in SCN5A, and displayed features of both LQTS and Brugada syndrome (Postema PG et al. J Cardiovasc Electrophysiol. 2011;22:590-3). In addition, in vitro studies in TSA201 cells suggested that this alteration changed intracellular protein localization and abolished channel current, indicating a possible trafficking defect (Cordeiro JM et al. Circulation. 2006;114:2026-33). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Cardiac arrhythmia Uncertain:1
This missense variant replaces isoleucine with valine at codon 1660 of the SCN5A protein. This variant is also known as p.Ile1659Val in the literature based on a different NM_000335 transcript. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). This variant is found within a highly conserved region of the transmembrane domain DIV. Rare nontruncating variants in this region are overrepresented in individuals with Brugada syndrome (PMID: 32893267). A functional study has shown that this variant causes a loss of sodium channel current and affects intracellular SCN5A protein trafficking (PMID: 17075016). This variant has been reported in at least seven unrelated individuals with Brugada syndrome (PMID: 17075016, 20812931, 26173111, 29709101, 32268277, 32893267, 34649698, 36516610, 37061847) and in a few individuals suspected of having Brugada syndrome (PMID: 20129283, 29759671, 30847666). One of the affected individuals carried an additional pathogenic variant in the SCN5A gene and exhibited severe ECG abnormalities with a mixed phenotypic expression of Brugada syndrome and long QT syndrome (PMID: 20812931). This variant has also been reported in individuals with long QT syndrome (PMID: 16414944, 32893267), dilated cardiomyopathy (PMID: 36178741), noncompaction cardiomyopathy (PMID: 29447731), in an individual with hypertrophic cardiomyopathy who also carried a pathogenic variant in the MYBPC3 gene (PMID: 32746448), and in individuals with ventricular arrhythmia or other SCN5A-related conditions (ClinVar SCV001220057.3; communication with an external lab; Color internal data). This variant has been identified in 9/282866 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Although there is a suspicion for a pathogenic role, the available evidence is not sufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Congenital long QT syndrome Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:16414944). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at